BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1
278 results:

  • 1. A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines.
    Cheng F; Li P; Xu S; Zhang C; Liang H; Ding Z
    Aging (Albany NY); 2024 Feb; 16(5):4396-4422. PubMed ID: 38407980
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study.
    Tassone P; Di Martino MT; Arbitrio M; Fiorillo L; Staropoli N; Ciliberto D; Cordua A; Scionti F; Bertucci B; Salvino A; Lopreiato M; Thunarf F; Cuomo O; Zito MC; De Fina MR; Brescia A; Gualtieri S; Riillo C; Manti F; Caracciolo D; Barbieri V; Di Paola ED; Di Francesco AE; Tagliaferri P
    J Hematol Oncol; 2023 Jun; 16(1):68. PubMed ID: 37365583
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Opportunities for Achieving the cancer Moonshot Goal of a 50% Reduction in cancer Mortality by 2047.
    Shiels MS; Lipkowitz S; Campos NG; Schiffman M; Schiller JT; Freedman ND; Berrington de González A
    Cancer Discov; 2023 May; 13(5):1084-1099. PubMed ID: 37067240
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular profiling of colorectal cancer in a genetically admixed Hispanic population.
    Montes-Rodríguez IM; Centeno-Girona H; Rivera-Lynch C; Rivera N; Cruz-Correa M
    Cancer Med; 2023 May; 12(10):11686-11702. PubMed ID: 37039257
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study.
    Maleux G; Albrecht T; Arnold D; Bargellini I; Cianni R; Helmberger T; Kolligs F; Munneke G; Peynircioglu B; Sangro B; Schaefer N; Pereira H; Zeka B; de Jong N; Bilbao JI;
    Cardiovasc Intervent Radiol; 2023 Jul; 46(7):852-867. PubMed ID: 36914788
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Crosstalk between protein kinase C α and transforming growth factor β signaling mediated by Runx2 in intestinal epithelial cells.
    Li X; Kaur N; Albahrani M; Karpf AR; Black AR; Black JD
    J Biol Chem; 2023 Apr; 299(4):103017. PubMed ID: 36791912
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Examination of colorectal cancer cases with metal allergy.
    Mizukoshi K; Okazawa Y; Amemiya K; Tsuchiya Y; Motegi S; Tsukamoto R; Honjo K; Takahashi R; Yoshihara N; Kawano S; Kawai M; Munakata S; Ishiyama S; Sugimoto K; Takahashi M; Kojima Y; Ikeda S; Sakamoto K
    Surg Today; 2023 Jul; 53(7):753-761. PubMed ID: 36757618
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. EMERGENCY SURGERY FOR OBSTRUCTING COLON cancer: MORBIDITY AND RISK FACTORS OF EARLY POSTOPERATIVE MORTALITY - A COHORT STUDY OF 118 CASES.
    Zaafouri H; Cherif M; Khedhiri N; Mesbahi M; Zebda H; Jouini R; Bellali H; Ben Maamer A
    Arq Bras Cir Dig; 2023; 35():e1706. PubMed ID: 36629687
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of a novel prognostic signature correlated with epithelial-mesenchymal transition, N6-methyladenosine modification, and immune infiltration in colorectal cancer.
    Qu X; Tan H; Mao J; Yang M; Xu J; Yan X; Wu W
    Cancer Med; 2023 Mar; 12(5):5926-5938. PubMed ID: 36281556
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy.
    de Almeida LC; Carlos JAEG; Rezende-Teixeira P; Machado-Neto JA; Costa-Lotufo LV
    Life Sci; 2022 Nov; 308():120911. PubMed ID: 36030982
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Immunohistochemical determination of mismatch repair gene product in colorectal carcinomas in a young indigenous African cohort.
    Holla R; Vorster A; Locketz M; De Haas M; Oke OA; Govender D; Ramesar R; Goldberg PA
    S Afr J Surg; 2022 Mar; 60(1):28-33. PubMed ID: 35451266
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Effect of Sodium Butyrate on p16INK4a, p14ARF, p15INK4b, Class I HDACs (HDACs 1, 2, 3) Class II HDACs (HDACs 4, 5, 6), Cell Growth Inhibition and Apoptosis Induction in Pancreatic cancer AsPC-1 and Colon cancer HCT-116 Cell Lines.
    Sanaei M; Kavoosi F
    Asian Pac J Cancer Prev; 2022 Mar; 23(3):795-802. PubMed ID: 35345349
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Detection of Colonic Polyps During Colonoscopy in a Tertiary Care Center of Nepal.
    Koirala D; Pathak R; Kafle Bhandari B; Jha A; Hamal R; Gnawali A; Pandey R; Bhusal M
    J Nepal Health Res Counc; 2021 Dec; 19(3):596-602. PubMed ID: 35140437
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Functional assessment of miR‑1291 in colon cancer cells.
    Wang J; Yokoyama Y; Hirose H; Shimomura Y; Bonkobara S; Itakura H; Kouda S; Morimoto Y; Minami K; Takahashi H; Shibata S; Kobayashi S; Uemura M; Tanaka S; Wu X; Tanaka S; Mori M; Yamamoto H
    Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 34981812
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer.
    Rampioni Vinciguerra GL; Dall'Acqua A; Segatto I; Mattevi MC; Russo F; Favero A; Cirombella R; Mungo G; Viotto D; Karimbayli J; Pesce M; Vecchione A; Belletti B; Baldassarre G
    Cell Death Dis; 2021 Oct; 12(10):951. PubMed ID: 34654798
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. RAS specific protease induces irreversible growth arrest via p27 in several KRAS mutant colorectal cancer cell lines.
    Stubbs CK; Biancucci M; Vidimar V; Satchell KJF
    Sci Rep; 2021 Sep; 11(1):17925. PubMed ID: 34504197
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Achalasia and acromegaly: Co-incidence of these diseases or a new syndrome?
    Dolina J; Kunovsky L; Kroupa R; Stary K; Jabandziev P; Nesporova T; Maca K; Andrasina T; Marek F; Kala Z; Vaculova J; Said D; Zapletalova M; Lochman J; Palova Noskova H; Slaby O; Izakovicova Holla L; Borilova Linhartova P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):228-235. PubMed ID: 34282806
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Quantitative FIT stratification is superior to NICE referral criteria NG12 in a high-risk colorectal cancer population.
    Bailey JA; Ibrahim H; Bunce J; Chapman CJ; Morling JR; Simpson JA; Humes DJ; Banerjea A
    Tech Coloproctol; 2021 Oct; 25(10):1151-1154. PubMed ID: 34263362
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. State-of-the-art colorectal disease: postoperative ileus.
    Sommer NP; Schneider R; Wehner S; Kalff JC; Vilz TO
    Int J Colorectal Dis; 2021 Sep; 36(9):2017-2025. PubMed ID: 33977334
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Comparison of the Anti-cancer Effects of Free and PLGA-PAA Encapsulated Hydroxytyrosol on the HT-29 colorectal cancer Cell Line.
    Sani NS; Onsori H; Akrami S; Rahmati M
    Anticancer Agents Med Chem; 2022; 22(2):390-394. PubMed ID: 33687886
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 14.